Fosun Pharmaceutical Group actively implements and promotes the central government’s “precise poverty alleviation and precision poverty alleviation” decision-making and deployment, and gives full play to its advantages in the pharmaceutical and medical and health industries. Through various measures, the current focus is on poverty alleviation through industrial development, education and health. , Carry out targeted poverty alleviation work in terms of security and social poverty alleviation.
In 2016, in accordance with the overall poverty alleviation strategy of Fosun Pharmaceutical Group, a number of poverty alleviation work was carried out, and the "Double Thousand Project" was one of them. In March 2016, Fosun Pharma and Hongqi Pharmaceutical, a member company, donated 1 million yuan to the China National Tuberculosis Association through the Fosun Foundation to launch the "Double Thousand Action" project for tuberculosis poverty relief, providing funds, medicines and other forms of support.
The "Double Thousand Action" project will bring good news to poor tuberculosis patients. This is also a conscious action of Fosun Pharma to thank the society and give back to the society. As a member of the medical and health industry, Fosun Pharma is committed to helping patients, especially impoverished patients, receive timely assistance, so that they can regain a healthy and happy life. In the future, Fosun Pharma will continue to pay attention to and support China's anti-tuberculosis cause.
*The following is transferred from the official WeChat of the China National Tuberculosis Association
China Anti-tuberculosis Association, Fosun Public Welfare Foundation, and Fosun Pharma’s member company Shenyang Hongqi Pharmaceutical Co., Ltd. launched the China National Defence Tuberculosis Public Welfare Fund and China National Defence Tuberculosis Public Welfare Fund-Tuberculosis from December 29, 2016 to March 5, 2017 Poverty relief "Double Thousand Action" project logo (Logo) solicitation of creative contest activities, the selection work has ended on March 15. This event collected more than 150 works in 75 groups submitted by 65 authors from 57 cities across the country. After the evaluation of the expert review panel, a total of one first prize (the winning work), five second prizes, and seven third prizes were selected. Thanks to the active participation of design enthusiasts across the country, the winning works are now announced as follows:
First prize (selected works in the "Double Thousand Action" project) exhibition (1 person)
Author: Liwen Fei Zhanjiang City of Guangdong Province, Ma policies intended to studio
Second Prize Works Exhibition (5 winners)
Author: Fusheng Yun, Shandong Province, Jinan ShangXi brand design company
Author: Pang Mincong Beijing Ya send brand design agency Design Company
Author: Huizhou City, Guangdong Province, Li Xiaofen Institute of Tuberculosis Prevention
Author: Wang Geng Nanyang City, Henan Province, Celestica creative company
Author: Zhou Kun Chan in Shanghai
Third Prize Works Exhibition (7 winners)
Author: Zhaoyang District of Zhaotong City of Yunnan Province Li Tinggang Center for Disease Control and Prevention
Author: Changzhou City, Jiangsu Province, Sheng Zhang Xuesheng and Culture
Author: Huang Jianrong Zhongshan City, Guangdong Zhongshan Yuantu advertising company
Author: Zhou Xiaofeng Henan Zhoukou Normal University College of Design
Author: Hsiu Hang Fuding City of Fujian Province
Author: Quanzhou, Fujian dream Xiang Liu Zhuchang visual studio
Author: Zhuang Welcome Longkou City, Shandong Province Civil Affairs Bureau
March 17, 2017 to March 23, 2017
1. All submitted works must not infringe the copyrights of others. Once discovered, their qualifications for evaluation will be cancelled. All legal responsibilities shall be borne by the author himself, and have nothing to do with the collection unit;
2. Once the work is adopted, its ownership and use rights belong to the organizer, and it has the right to use, develop, modify, authorize, license or declare intellectual property protection in any form. Applicants are not allowed to use, transfer to a third party for use or publication, etc.; 3. The organizer of this event has the final interpretation right.
China Tuberculosis Association
March 17, 2017
Link: "Double Thousand Action" allows all tuberculosis patients to receive timely assistance and care
March 24, 2016 is the 21st World Tuberculosis Day. my country’s propaganda theme is "Society work together to eliminate the hazards of tuberculosis". The China Anti-tuberculosis Association established the “China National Tuberculosis Public Welfare Fund” and, together with Fosun Public Welfare Foundation, and Fosun Pharma’s member company Hongqi Pharmaceutical, jointly launched the China National Tuberculosis Public Welfare Fund-Tuberculosis Poverty Relief "Double Thousand Action" project.
On March 22, 2016, the "Double Thousand Action" project was announced at the theme publicity event of World Tuberculosis Day jointly sponsored by the National Health and Family Planning Commission and the Beijing Municipal People's Government. The "Double Thousand Action" project started in 2016 and lasted for five years from 2020. It can save at least 1,000 poor tuberculosis patients each year, and each patient's assistance fund is at least 1,000 yuan. The Fosun Charity Foundation and Hongqi Pharmaceutical, a member company of Fosun Pharma, will continue to support this project by providing funding, medicines and other forms of sponsorship.
On April 27, the 2016 National Academic Conference of the China National Tuberculosis Association was held in Zhuhai City, Guangdong Province, and the opening ceremony of the China National Tuberculosis Public Welfare Fund was officially held at the opening ceremony.
As the country's largest anti-tuberculosis drug R&D and production base, Hongqi Pharmaceutical has made important contributions to the cause of China's tuberculosis defense. At present, its first-line anti-tuberculosis drugs are Rifampicin Capsules, Rifampicin Capsules II, Isoniazid Tablets, Ethambutol Tablets (Capsules), Pyrazinamide Tablets (Capsules), Prothionamide Enteric-coated Tablets, etc. Sales have always been in the forefront of the country. In particular, FDC (Fixed Dose Combination) products have two kinds of medicines taken daily and every other day. At present, Hongqi Pharmaceutical's anti-tuberculosis drugs have been serialized. Under the background of China's establishment and improvement of a new type of tuberculosis prevention and treatment system, Hongqi Pharmaceuticals will innovate more good products and make greater contributions to the cause of China's tuberculosis defense.